Insider trades by month
US insider trades, October 2026
The 850 open-market buys and sales by US company CEOs, executives and directors filed in October 2026.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
eHealthEHTH | Open-market sale10b5-1 plan | 10/01–10/02 | 10/02 | 40,612 sh2 trades | $0.69avg. | $28,174.58 | −4.0% | |
Butler NationalBUKS | Open-market buy | 10/01–10/02 | 10/02 | 15,000 sh3 trades | $4.09avg. | $61,387.1 | +0.3% | |
SnowflakeSNOW | Open-market sale10b5-1 plan | 10/02 | 10/02 | 50,741 sh7 trades | $344.00avg. | $17,454,904 | No record | |
Jewett Cameron TradingJCTC | Open-market buy | 09/30–10/02 | 10/02 | 7,916 sh6 trades | $2.91avg. | $23,066.86 | +1.6% | |
MetallusMTUS | Open-market sale10b5-1 plan | 10/02 | 10/02 | 12,570 sh | $20.01 | $251,482.96 | −1.7% | |
David Joseph GaffinEVP, CLO, Alkermes, Inc | AlkermesALKS | Open-market sale10b5-1 plan | 10/02 | 10/02 | 2,034 sh | $41.03 | $83,455.02 | −0.9% |
Ryan CohenPresident, CEO and Chairman | GameStopGME | Open-market buy | 10/02 | 10/02 | 700,000 sh | $24.41 | $17,084,270 | +1.7% |
Paul Cahill SciarraDirector | Joby AviationJOBY | Open-market sale10b5-1 plan | 10/02 | 10/02 | 62,500 sh | $6.09 | $380,625 | −0.1% |
Christine RingChief Legal Officer | Nurix TherapeuticsNRIX | Open-market sale10b5-1 plan | 10/02 | 10/02 | 5,786 sh | $23.19 | $134,148.99 | −38.8% |
XometryXMTR | Open-market sale10b5-1 plan | 10/01–10/02 | 10/02 | 15,721 sh11 trades | $103.78avg. | $1,631,505.53 | No record | |
CardlyticsCDLX | Open-market sale | 10/01–10/02 | 10/02 | 17,733 sh2 trades | $2.64avg. | $46,749.82 | −11.3% | |
Jonathan AllanGeneral Counsel & Corp Sec | Stoke TherapeuticsSTOK | Open-market sale10b5-1 plan | 10/02 | 10/02 | 627 sh | $26.33 | $16,508.91 | −3.0% |
XometryXMTR | Open-market sale10b5-1 plan | 10/02 | 10/02 | 1,112 sh6 trades | $103.28avg. | $114,851.19 | −0.6% | |
CTO | XometryXMTR | Open-market sale10b5-1 plan | 10/02 | 10/02 | 1,866 sh5 trades | $103.28avg. | $192,725.19 | −1.4% |
Patricia Y. GrechSVP, Chief Accounting Officer | QualcommQCOM | Open-market sale10b5-1 plan | 10/02 | 10/02 | 98 sh | $186.55 | $18,281.9 | −100.0% |
CEO | BioNTechBNTX | Open-market sale10b5-1 plan | 10/01–10/02 | 10/02 | 34,000 sh2 trades | $97.09avg. | $3,301,068.5 | −15.9% |
CEO | IntappINTA | Open-market sale10b5-1 plan | 09/30–10/01 | 10/02 | 3,000 sh2 trades | $36.70avg. | $110,102 | −0.1% |
Chairperson & CEO | United TherapeuticsUTHR | Open-market sale10b5-1 plan | 10/01 | 10/02 | 9,500 sh19 trades | $576.47avg. | $5,476,462.43 | −2.8% |
Edward MeyercordPresident and CEO | Extreme NetworksEXTR | Open-market sale10b5-1 plan | 10/01 | 10/02 | 50,000 sh | $21.77 | $1,088,585 | −2.8% |
Mary Agnes WilderotterDirector | DocusignDOCU | Open-market sale10b5-1 plan | 10/01 | 10/02 | 1,000 sh | $68.80 | $68,800 | −31.3% |
Other months
- October 2026850
- September 20261,713
- June 202613,650
- May 202611,853
- April 20267,370
- March 202611,386
- February 20269,308
- January 20266,824
- December 20259,931
- November 202510,022
- October 20257,932
- September 20259,083
- August 202511,333
- July 20256,568
- June 20258,438
- May 20259,580
- April 20255,521
- March 202510,555
- February 20259,496
- January 20256,927
- December 202411,021
- November 202413,298
- October 20246,127
- September 20248,102
- August 202411,053
- July 20246,992
- June 20248,779
- May 202410,373
- April 20246,464
- March 202413,691
- February 202411,643
- January 20247,422
- December 202310,058
- November 20239,957
- October 20235,130
- September 20237,540
- August 202310,263
- July 20235,593
- June 20238,632
- May 202310,751
- April 20234,599
- March 202310,574
- February 20239,397
- January 20236,394